Tarsus Pharmaceuticals
TARS
#4267
Rank
โ‚ฌ1.95 B
Marketcap
51,05ย โ‚ฌ
Share price
1.75%
Change (1 day)
179.52%
Change (1 year)

Revenue for Tarsus Pharmaceuticals (TARS)

Revenue in 2024 (TTM): โ‚ฌ0.11 Billion

According to Tarsus Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.12 Billion. In 2023 the company made a revenue of โ‚ฌ15.78 Million a decrease over the revenue in the year 2022 that were of โ‚ฌ24.06 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Tarsus Pharmaceuticals from 2020 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚ฌ0.11 B651.14%
2023 โ‚ฌ15.78 M-34.42%
2022 โ‚ฌ24.06 M-52.21%
2021 โ‚ฌ50.35 M
2020 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA